Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOGOS: Efficacy and Safety of PT010 in Inadequately Controlled Asthma
NCT04609904Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of budesonide, glycopyrrolate metered dose inhaler, formoterol in asthma, sponsored by AstraZeneca. Started Mar 2021; status: completed.
02
Drugs
budesonideglycopyrrolate metered dose inhalerformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04609904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04609904.